Streetwise Reports (10/01/2025)
Capricor Therapeutics Inc. (CAPR:NASDAQ) reached agreement with the FDA to include HOPE-3 trial data in its BLA for Deramiocel, its cell therapy for Duchenne muscular dystrophy. With topline results due in Q4, learn how the company is advancing one of the few late-stage programs in this high-need rare disease space. Streetwise Reports (10/01/2025)
Companies like K2 Gold (KTO:TSXV; KTGDF:OTCQB), White Gold Corp. (WGO:TSX.V; WHGOF:OTCQX; 29W:FRA), Cassiar Gold Corp. (GLDC:TSX.V; CGLCF:OTCQX; 756:FRA), and Thunderbird Minerals (BIRD:TSXV) are expanding exploration in BC and the Yukon. These juniors are targeting high-grade gold and copper in proven mineral belts like the Quesnel Terrane and Tombstone Gold Belt.